E-Cadherin upregulation was also more commonly seen in malignant (43/331; 13.0%) than in benign (23/327; 7.0%) soft tissue tumors (p = 0.0104, Supplementary Figure 1). The gene discussed is CDH1; the disease is soft tissue neoplasm.